D.E. Shaw & Co’s Icosavax, Inc. Common Stock ICVX Stock Holding History

D.E. Shaw & Co’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-23,715	Closed	-$374K	–	4896
2023 Q4	$374K	Buy	+23,715	New	+$228K	﹤0.01%	3658
2022 Q4	–	Sell	-74,000	Closed	-$234K	–	5248
2022 Q3	$234K	Buy	74,000 +3,245	+5%	+$20.3K	﹤0.01%	4408
2022 Q2	$405K	Sell	70,755 -18,427	-21%	-$144K	﹤0.01%	4220
2022 Q1	$628K	Buy	89,182 +67,409	+310%	+$1.06M	﹤0.01%	4230
2021 Q4	$498K	Buy	21,773 +2,266	+12%	+$58.5K	﹤0.01%	4406
2021 Q3	$577K	Buy	+19,507	New	+$661K	﹤0.01%	4005

D.E. Shaw & Co's ICVX Position: Q1 2024 in Review

D.E. Shaw & Co sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 23,715 shares — an estimated $374K sold.

D.E. Shaw & Co first reported a position in ICVX in Q3 2021 and held it in 6 quarters. The position peaked at $628K in Q1 2022. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

D.E. Shaw & Co reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
D.E. Shaw & Co sold 23,715 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $374K.
D.E. Shaw & Co first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
D.E. Shaw & Co's Icosavax, Inc. Common Stock position peaked at $628K in Q1 2022.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.